| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by (used in) financing activities | 2,470 | 598 |
| Effect of exchange rate changes on cash and cash equivalents | 139 | 234 |
| Net decrease in cash and cash equivalents | -37,141 | -19,765 |
| Cash and cash equivalents at beginning of period | 46,074 | - |
| Cash and cash equivalents at end of period | 8,933 | - |
Gossamer Bio, Inc. (GOSS)
Gossamer Bio, Inc. (GOSS)